Fig. 3From: Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based studyKaplan-Meier OS and GISTs-specific survival for patients with AM-GISTs and GISTs-1. Differences of OS (a) and GISTs-specific survival (b) were significant (p < 0.001, p = 0.002; respectively) between patients with AM-GISTs and GISTs-1. The OS (c) and GISTs-specific survival (d) grouped by first primary malignancy sitesBack to article page